Menier's Disease - Bone Density Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHaEmek Medical Center, Israel
About this trial
Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.
Eligibility criteria
Qualifiers
Definite Meniere's disease
Disqualifiers
hyperthyroidism
hyperparathyroidism
acromegaly
hypogonadism
Trial design
Treatments tested in this trial
- vitamin D plasma levels baseline
- Dual-energy X-ray absorptiometry at baseline
- cervical Vestibular evoked myogenic potentials at baseline
- Audiogram at baseline
- Measuring Orthostatic Blood Pressure at baseline
- cold pressor test at baseline
- vitamin D plasma levels one year after recruitment
- vitamin D plasma levels two years after recruitment
- Dual-energy X-ray absorptiometry one year after recruitment
- Dual-energy X-ray absorptiometry two years after recruitment
- cervical Vestibular evoked myogenic potentials one year after recruitment
- cervical Vestibular evoked myogenic potentials two years after recruitment
- Audiogram one year after recruitment
- Audiogram two years after recruitment
- Measuring Orthostatic Blood Pressure one year after recruitment
- Measuring Orthostatic Blood Pressure two years after recruitment
- cold pressor test one year after recruitment
- cold pressor test two years after recruitment
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
HaEmek Medical Center, Israel
Lead sponsor
Source ClinicalTrials.gov